Background The second consensus criteria for the diagnosis of multiple system atrophy
(MSA) are widely recognized as the reference standard for clinical research, but lack …

Background Consensus criteria for classifying tremor disorders were published by the
International Parkinson and Movement Disorder Society in 1998. Subsequent advances with …

Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …

Multiple-system atrophy is a neurodegenerative disease characterized by progressive
autonomic failure, parkinsonism, and cerebellar and pyramidal tract symptoms. Glial …

Dysfunction of the autonomic nervous system afflicts most patients with Parkinson disease
and other synucleinopathies such as dementia with Lewy bodies, multiple system atrophy …

Background Multiple system atrophy is a rare, fatal neurodegenerative disorder with
symptoms of autonomic failure plus parkinsonism, cerebellar ataxia, or both. We report …

Clinical diagnosis of multiple system atrophy is challenging and many patients with Lewy
body disease (ie Parkinson's disease or dementia with Lewy bodies) or progressive …

Background Parkinson's disease is characterized by intraneuronal α‐synuclein aggregation.
Currently there is no α‐synuclein‐based blood test in clinical practice. Objectives Our aim …

Multiple system atrophy (MSA) is an orphan, fatal, adult-onset neurodegenerative disorder of
uncertain etiology that is clinically characterized by various combinations of parkinsonism …

Objective To examine mortality and associated risk factors, including possible effects of mild
cognitive impairment, imaging, and CSF abnormalities, in a community-based population …